{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:52Z","timestamp":1772165932649,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Xanthine urinary stones are a rare entity that may occur in patients with Lesch\u2013Nyhan syndrome receiving allopurinol. There is little literature describing imaging characteristics of these stones, and the most appropriate approach to imaging these stones is therefore unclear. We performed in-vitro and in-vivo analyses of xanthine stones using computed tomography (CT) at different energy levels, ultrasound (US), and magnetic resonance imaging (MRI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Five pure xanthine stones from a child with Lesch-Nyhan were imaged in-vitro and in-vivo. CT of the stones was performed at 80\u00a0kVp, 100\u00a0kVp, 120\u00a0kVp and 140\u00a0kVp and CT numbers of the stones were recorded in Hounsfield units (HU). US of the stones was performed and echogenicity, acoustic shadowing and twinkle artifact were assessed. MRI of the stones was performed and included T2-weighted, ultrashort echo-time-weighted and T2\/T1-weighted 3D bFFE sequences and signal was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In-vitro analysis on CT demonstrated that xanthine stones were radiodense and the average attenuation coefficient did not differ with varying kVp, measuring 331.0\u2009\u00b1\u200951.7 HU at 80\u00a0kVp, 321.4\u2009\u00b1\u200963.4 HU at 100\u00a0kVp, 329.7\u2009\u00b1\u200954.2 HU at 120\u00a0kVp and 328.4\u2009\u00b1\u200961.1 HU at 140\u00a0kVp. In-vivo analysis on CT resulted in an average attenuation of 354\u2009\u00b1\u200935 HU. On US, xanthine stones where echogenic with acoustic shadowing and twinkle artifact. On MRI, stones lacked signal on all tested sequences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Xanthine stone analyses, both in-vitro and in-vivo, demonstrate imaging characteristics typical of most urinary stones: dense on CT, echogenic on US, and lacking signal on MRI. Therefore, the approach to imaging xanthine stones should be comparable to that of other urinary stones.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-020-00736-w","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T09:02:56Z","timestamp":1602493376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CT, US and MRI of xanthine urinary stones: in-vitro and in-vivo analyses"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6450-6487","authenticated-orcid":false,"given":"Stephanie B.","family":"Shamir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan H.","family":"Schoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth A.","family":"Drzewiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Liszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"issue":"2","key":"736_CR1","first-page":"328","volume":"21","author":"T Gargah","year":"2010","unstructured":"Gargah T, et al. Xanthine urolithiasis. Saudi J Kidney Dis Transpl. 2010;21(2):328\u201331.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"5","key":"736_CR2","doi-asserted-by":"publisher","first-page":"1084.e9","DOI":"10.1016\/j.urology.2005.10.057","volume":"67","author":"VM Pais Jr","year":"2006","unstructured":"Pais VM Jr, et al. Xanthine urolithiasis. Urology. 2006;67(5):1084.e9\u201311.","journal-title":"Urology"},{"issue":"10","key":"736_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/1098612X13477413","volume":"15","author":"LA Mestrinho","year":"2013","unstructured":"Mestrinho LA, et al. Xanthine urolithiasis causing bilateral ureteral obstruction in a 10-month-old cat. J Feline Med Surg. 2013;15(10):911\u20136.","journal-title":"J Feline Med Surg"},{"issue":"1","key":"736_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0090-4295(85)90256-0","volume":"26","author":"A Ogawa","year":"1985","unstructured":"Ogawa A, Watanabe K, Minejima N. Renal xanthine stone in Lesch\u2013Nyhan syndrome treated with allopurinol. Urology. 1985;26(1):56\u20138.","journal-title":"Urology"},{"issue":"5","key":"736_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/mrm.20868","volume":"55","author":"J Rahmer","year":"2006","unstructured":"Rahmer J, et al. Three-dimensional radial ultrashort echo-time imaging with T2 adapted sampling. Magn Reson Med. 2006;55(5):1075\u201382.","journal-title":"Magn Reson Med"},{"issue":"3","key":"736_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2214\/ajr.142.3.545","volume":"142","author":"JH Newhouse","year":"1984","unstructured":"Newhouse JH, et al. Computed tomographic analysis of urinary calculi. AJR Am J Roentgenol. 1984;142(3):545\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"736_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0090-4295(01)01115-3","volume":"58","author":"G Motley","year":"2001","unstructured":"Motley G, et al. Hounsfield unit density in the determination of urinary stone composition. Urology. 2001;58(2):170\u20133.","journal-title":"Urology"},{"issue":"2","key":"736_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.urology.2004.03.029","volume":"64","author":"S Deveci","year":"2004","unstructured":"Deveci S, et al. Spiral computed tomography: role in determination of chemical compositions of pure and mixed urinary stones\u2014an in vitro study. Urology. 2004;64(2):237\u201340.","journal-title":"Urology"},{"issue":"1","key":"736_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clinimag.2015.09.005","volume":"40","author":"SH el Ibrahim","year":"2016","unstructured":"el Ibrahim SH, et al. Detection of different kidney stone types: an ex vivo comparison of ultrashort echo time MRI to reference standard CT. Clin Imaging. 2016;40(1):90\u20135.","journal-title":"Clin Imaging"},{"issue":"12","key":"736_CR10","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.acra.2012.07.008","volume":"19","author":"A Yassin","year":"2012","unstructured":"Yassin A, et al. In vitro MR imaging of renal stones with an ultra-short echo time magnetic resonance imaging sequence. Acad Radiol. 2012;19(12):1566\u201372.","journal-title":"Acad Radiol"},{"issue":"2","key":"736_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2214\/ajr.175.2.1750329","volume":"175","author":"KC Saw","year":"2000","unstructured":"Saw KC, et al. Helical CT of urinary calculi: effect of stone composition, stone size, and scan collimation. AJR Am J Roentgenol. 2000;175(2):329\u201332.","journal-title":"AJR Am J Roentgenol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00736-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-020-00736-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00736-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T03:44:25Z","timestamp":1634010265000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-020-00736-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1186\/s12894-020-00736-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-29107\/v7","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29107\/v8","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29107\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29107\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29107\/v5","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29107\/v6","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29107\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29107\/v2","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Although the need for consent to participate was waived, informed consent for publication was obtained from the patient\u2019s parent. The patient data was obtained from a patient at our institution. No administrative permissions and\/or licenses were acquired by our team to access the data used in our research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"B.A.D. is a consultant for Astellas Pharma Europe for a separate, unrelated study. M.C.L. received an industry grant from Carestream Health for a separate, unrelated study, Study # 17-10-77.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}